237 related articles for article (PubMed ID: 12581269)
1. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem.
Dang CN; Prasad YD; Boulton AJ; Jude EB
Diabet Med; 2003 Feb; 20(2):159-61. PubMed ID: 12581269
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.
Tentolouris N; Jude EB; Smirnof I; Knowles EA; Boulton AJ
Diabet Med; 1999 Sep; 16(9):767-71. PubMed ID: 10510954
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].
Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers.
Tentolouris N; Petrikkos G; Vallianou N; Zachos C; Daikos GL; Tsapogas P; Markou G; Katsilambros N
Clin Microbiol Infect; 2006 Feb; 12(2):186-9. PubMed ID: 16441460
[TBL] [Abstract][Full Text] [Related]
5. Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.
Ambrosch A; Haefner S; Jude E; Lobmann R
Int Wound J; 2011 Dec; 8(6):567-77. PubMed ID: 21883937
[TBL] [Abstract][Full Text] [Related]
6. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R
Int J Low Extrem Wounds; 2014 Mar; 13(1):12-6. PubMed ID: 24659622
[TBL] [Abstract][Full Text] [Related]
7. Nasal MRSA carriage is a risk factor for development of antibiotic resistance in diabetic foot ulcers and is significantly higher than diabetic and non-diabetic individuals without foot ulcer.
Mukherjee P; Paul S; Dutta T; Nath S; Ghosh B; Chatterjee D; Mukhopadhyay S; Mukherjee S
BMC Infect Dis; 2023 Oct; 23(1):729. PubMed ID: 37884870
[TBL] [Abstract][Full Text] [Related]
8. Microbiological pattern of diabetic foot infections at a tertiary care center in a developing country.
Miyan Z; Fawwad A; Sabir R; Basit A
J Pak Med Assoc; 2017 May; 67(5):665-669. PubMed ID: 28507348
[TBL] [Abstract][Full Text] [Related]
9. Reduction in the prevalence of methicillin-resistant Staphylococcus aureus in tissue and wound swab samples taken from outpatients attending a specialist diabetic foot clinic 2005-2021.
Moore J; Gooday C; Soliman R; Dhatariya K
Diabet Med; 2023 Oct; 40(10):e15081. PubMed ID: 36883882
[TBL] [Abstract][Full Text] [Related]
10. Infections of diabetic foot ulcers with methicillin-resistant Staphylococcus aureus.
Cervantes-García E; García-González R; Reséndiz-Albor A; Salazar-Schettino PM
Int J Low Extrem Wounds; 2015 Mar; 14(1):44-9. PubMed ID: 25573977
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.
Reveles KR; Duhon BM; Moore RJ; Hand EO; Howell CK
PLoS One; 2016; 11(8):e0161658. PubMed ID: 27556897
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of the microbiology of diabetic foot infections at a Scottish tertiary hospital.
Macdonald KE; Jordan CY; Crichton E; Barnes JE; Harkin GE; Hall LML; Jones JD
BMC Infect Dis; 2020 Mar; 20(1):218. PubMed ID: 32164543
[TBL] [Abstract][Full Text] [Related]
14. The Most Prevalent Organism in Diabetic Foot Ulcers and Its Drug Sensitivity and Resistance to Different Standard Antibiotics.
Nageen A
J Coll Physicians Surg Pak; 2016 Apr; 26(4):293-6. PubMed ID: 27097700
[TBL] [Abstract][Full Text] [Related]
15. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R
Int J Low Extrem Wounds; 2013 Jun; 12(2):100-5. PubMed ID: 23771610
[TBL] [Abstract][Full Text] [Related]
16. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.
Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF
BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061
[TBL] [Abstract][Full Text] [Related]
17. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?
Zenelaj B; Bouvet C; Lipsky BA; Uçkay I
Int J Low Extrem Wounds; 2014 Dec; 13(4):263-72. PubMed ID: 25288579
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage.
Stanaway S; Johnson D; Moulik P; Gill G
Diabetes Res Clin Pract; 2007 Jan; 75(1):47-50. PubMed ID: 16963148
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-Resistant
Viswanathan V; Pendsey S; Radhakrishnan C; Rege TD; Ahdal J; Jain R
Int J Low Extrem Wounds; 2019 Sep; 18(3):236-246. PubMed ID: 31256689
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections.
Joseph WS; Quast T; Cogo A; Crompton MG; Yoon MJ; Lamp KC; Culshaw D; Chaves RL
J Am Podiatr Med Assoc; 2014 Mar; 104(2):159-68. PubMed ID: 24725036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
